Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 330 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32022R0692

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32022R0692

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX V PŘENESENÉ XXXXXXXXX (EU) 2022/692

xx xxx 16. února 2022,

xxxxxx xx xxx účely xxxxxxxxxxxx vědeckotechnickému xxxxxxx xxxx xxxxxxxx Evropského xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx pro EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,

x&xxxx;xxxxxxx xx nařízení Evropského xxxxxxxxxx a Rady (XX) x.&xxxx;1272/2008 ze dne 16.&xxxx;xxxxxxxx&xxxx;2008 o klasifikaci, xxxxxxxxxx x&xxxx;xxxxxx látek a směsí, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (ES) č. 1907/2006 (1), x&xxxx;xxxxxxx na čl. 37 xxxx.&xxxx;5 xxxxxxxxx xxxxxxxx,

xxxxxxxx x&xxxx;xxxxx xxxxxxx:

(1)

Xxxxxxx 3 x&xxxx;xxxxx 3 přílohy XX xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx xxxxx na xxxxxxx kritérií xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx I uvedeného xxxxxxxx.

(2)

Xxxxxxxx agentuře xxx xxxxxxxx xxxxx (xxxx xxx „agentura“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) č. 1272/2008 předloženy xxxxxx xx zavedení xxxxxxxxxxxxx klasifikace a označení xxxxxxxxx xxxxx a na xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx klasifikací x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx xxxxx. Xxxx, co Výbor xxx posuzování xxxxx (XXX) agentury xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx stran, xxxxxx x&xxxx;xxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;(2):

—

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, produkty xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx syntetický xxxxxxx xxxx xxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx úpravou,

—

stanovisko ze xxx 4. května 2020 xxx xxxxxxxxxx (XXX), [(3-fenoxy-4-fluorfenyl)kyanmethyl]-3-(2,2-dichlorvinyl)-2,2-dimethylcyklopropan-1-karboxylát,

—

stanovisko xx xxx 4.&xxxx;xxxxxx&xxxx;2020 xxx β-xxxxxxxxxx (XXX); xxxxxxx směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx x&xxxx;xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx- (1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 4. května 2020 xxx xxxxxxxxxxx (XXX); (1X)-X-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X’-xxxx-X-xxxxxxxxxxxxxxxxxxx; (X)-X 1-[(6-chlor-3-pyridyl)methyl]-N 2-xxxx-X 1-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro tellur,

—

stanovisko xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxx xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx,

—

xxxxxxxxxx xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro piperonylbutoxid (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxx,

—

xxxxxxxxxx ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx daminozid (XXX); 4-(2,2-dimethylhydrazino)-4-oxobutanovou kyselinu; X-(xxxxxxxxxxxxx)xxxxxxxxxxxx kyselinu,

—

stanovisko ze xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (ISO); 3,6-bis(o-chlorfenyl)-1,2,4,5-tetrazin,

—

stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 pro trichlorsilan,

—

stanovisko xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxx 2-ethylhexanovou xxxxxxxx x&xxxx;xxxx xxxx,

—

xxxxxxxxxx xx xxx 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxx {[(karboxymethyl)imino]bis(ethylennitrilo)}tetraoctové kyseliny x&xxxx;xxxxxx pentasodných x&xxxx;xxxxxxxxxxxxxxx xxxx xx žádost Xxxxxxxx komise,

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx),

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx dne 17. září 2020 xxx tetraoxid xxxxxxx-xxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 4,4’-xxxxx(xxxxxxxxxxxxxxxxxxxxx),

—

xxxxxxxxxx xx dne 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxx-4-xxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro xxxxxxxxx; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,3-xxx(1-xxxxxxxxxx-1-xxxxxxxxxxx)xxxxxx; [x-XXXXX],

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,3-xxx(xxxxxxxxxxxxxxxx)xxxxxx; [m-XDI],

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx xxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx; xxxxxxxxxxxxxxxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 17.&xxxx;xxxx&xxxx;2020 xxx 1,5-xxxxxxxxxxxxxxxxxxxx [xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx 50 μm],

—

stanovisko xx xxx 17.&xxxx;xxxx&xxxx;2020 pro 1,5-xxxxxxxxxxxxxxxxxxxx [obsahující ≥&xxxx;0,1&xxxx;% xxxx. částic s aerodynamickým xxxxxxxx xxxxxx než 50 μx],

—

xxxxxxxxxx xx xxx 8. října 2020 pro xxxxxx amonný,

—

stanovisko xx xxx 8.&xxxx;xxxxx&xxxx;2020 pro 2,4,6-xxx-xxxx-xxxxxxxxxx,

—

xxxxxxxxxx xx dne 8.&xxxx;xxxxx&xxxx;2020 xxx pyridalyl (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxx-2-xxxxx-1-xxxx, xxxxxx sůl; xxxxxx xxx xxxxxxxxxx; xxxxxxxxx xxxxx,

—

xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 pro X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 8.&xxxx;xxxxx&xxxx;2020 xxx 2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 8. října 2020 pro 4,4′-xxxxxxxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx pendimethalin (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx,

—

xxxxxxxxxx xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxxxxxxxxx (XXX); (2E)-2-{2-[(2,5-dimethylfenoxy)methyl]fenyl}-2-(methoxyimino)-N-methylacetamid; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx 4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Blue 124,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx kyselinu xxxxxxxxxxxxxxxxxx; xxxxxxxx tridekafluorheptanovou,

—

stanovisko xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxx-X-(xxxxxxxxxxxxxxxxxx)-X-xxxxx-(3XX)-3-(4-xxxxxxxxxx)-β-xxxxxxxx; valifenalát,

—

stanovisko xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[alkyl-(C12-C18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx kyselinu, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx xxxx,

—

xxxxxxxxxx ze xxx 10. prosince 2020 pro 6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx ze dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxx 1,3,5-xxxxxxx-2,4,6-xxxxxxx; xxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxx reakční směs: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 10. prosince 2020 xxxxxxx xxxxxxx, xxxxxxxx [x&xxxx;xxxxx rostliny Xxxxxxxxxxx xxxxxx, xxxxxxxxxxx xxxxx x&xxxx;xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx],

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxx xxxxxxxxx,

—

xxxxxxxxxx xx xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxx xxxxxxxx (XXX), 3-isopropyl-2,1,3-benzothiadiazin-4-on-2,2-dioxid,

—

stanovisko ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxx xxxxxxxxx o akutní xxxxxxxxx xxxxxxxx 2-xxxxxxxxxxx-1-xxx; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx xxxxxx.

(3)

Xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxx xxxxxxxxxxx vědecké posouzení xxxxxxx xx stanoviscích XXX xx dne 11.&xxxx;xxxxxx&xxxx;2020 pro 2-xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx soli; xx dne 11.&xxxx;xxxxxx&xxxx;2020 xxxxxxx xxxxxxxxxx posouzení xxxxxxxx toxicity {[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxxx solí xx xxxxxx Xxxxxxxx xxxxxx, xx xxx 8.&xxxx;xxxxx&xxxx;2020 xxx xxxxxx amonný, xx xxx 10. prosince 2020 xxx xxxx xxxxxxxxx, xx dne 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxx opětovného posouzení xxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxx xxxxxxxx 2-butoxyethan-1-olu; xxxxxxxxxxxxx-xxxxxxxxx-xxxxxx (XXXX) xx xxxxxx Xxxxxxxx komise x&xxxx;xx xxx 10. prosince 2020 xxx melamin.

(4)

Komise tyto xxxxxxxxx xxxxxxxxx posoudila x&xxxx;xxxxxxxxxx xx za xxxxxxxxxx k tomu, aby xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxx xx xxxxxxxxxxxx XXX. Xx základě xxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxx xx xxxxx xxxxxx zavést, xxxxxxxxxxxx xxxx xxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx.

(5)

Xxxx, co xxxx Xxxxxx xxxxxxx stanovisko XXX, xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx s oxidem xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxx křemičitého x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx. Xxxxxxxxxxx xxxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, xxxxxxxx xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx oxidu xxxxxxxxxxx x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxx kategorie 2, xxxxxxxxxx ve stanovisku XXX xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019, xx neměla xxx xxxxxxxx xx xxxxxxx VI xxxxxxxx (XX) x.&xxxx;1272/2008, neboť Xxxxxx xxxx xxxxxxx xxxxxxxxx xxxxxxxxx a neshledala, xx xx bylo xxxxx xxxxx xxxxxxxxx XXX. Do xxxxxxx XX nařízení (XX) x.&xxxx;1272/2008 by xxxx xxxx xxx xxxxxxxx xxxxxxxxxxx xxxx xxxxx xxxx STOT RE 2, xxxxxxxxxx xx xxxxxxxxxx výboru XXX xx dne 5. prosince 2019, xxxxx xxxxxx obdrženy xxxxx xxxx informace, xxxxx xx vyžadovaly xxxxx xxxxxxxxx xxxx xxxxxxxxxxx.

(6)

Xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx nemělo xxx xxxxxxxxxx xxxxx, xxxxxxx xxxxxxxxxx xxxxxxxxx určitou xxxx xx xx, xxx xxxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx látek x&xxxx;xxxxx xxxxx xxxx aktualizovaným xxxxxxxxxxxx x&xxxx;xxxxxxx xxxxxxxxx xxxxxx, xx xxxxx xx vztahují xxxxxxxxx xxxxxxxxxxx xxxxxxxxx. Xxxx xxxx xx xxxxxx xxxxxxxx k tomu, aby xxxxxxxxxx měli xxxxxxxx xxxx xxxxxxxx xxxxxxxx xxxxx k zajištění xxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx xxxxxxxxx, xxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxx xxxxxxxxxxx xxxxx xxxxxx xxxxxxxx. Xxxxxxxxxxx by však xxxx xxx xxxxxxxx xxxxxxxx xxxx xxxx xxxxxxxxxxxxx harmonizované klasifikace x&xxxx;xxxxxxxxxxxxx způsobem xxxxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxx xx xxxxxxxxxxx xxxxxxx xxxx xxxxx použitelnosti xxxxxx xxxxxxxx, xxx xxxx xxxxxxxxx vysoká xxxxxx xxxxxxx lidského xxxxxx x&xxxx;xxxxxxxxx xxxxxxxxx a aby xx dodavatelům xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (ES) x.&xxxx;1272/2008

Xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 se xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxx xxxxxx nařízení.

Xxxxxx&xxxx;2

Xxxxx v platnost x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx v Úředním xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx se xxx xxx 23.&xxxx;xxxxxxxxx 2023.

Xxxxxxxx od druhého xxxxxxxxxxx xxxxxx xxxxxx xxxxx být xxxxx x&xxxx;xxxxx xxxxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx v platnost.

Xxxx xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx použitelné xx xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 16. února 2022.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx VON XXX XXXXX

(1)&xxxx;&xxxx;Xx. xxxx. L 353, 31.12.2008, s. 1.

(2)  Stanoviska xxxx xxxxxxxx na této xxxxxxxxxxx stránce: https://echa.europa.eu/registry-of-clh-intentions-until-outcome/-/dislist/name/-/ecNumber/-/casNumber/-/dte_receiptFrom/-/dte_receiptTo/-/prc_public_status/Opinion+Adopted/dte_withdrawnFrom/-/dte_withdrawnTo/-/sbm_expected_submissionFrom/-/sbm_expected_submissionTo/-/dte_finalise_deadlineFrom/-/dte_finalise_deadlineTo/-/haz_addional_hazard/-/lec_submitter/-/dte_assessmentFrom/-/dte_assessmentTo/-/prc_regulatory_programme/-/. – Xxxxxxxxxx xx xxx 11. června 2020 a ze xxx 10.&xxxx;xxxxxxxx&xxxx;2020 xxxxxxxx xx xxxxxxxxxx posouzení xx xxxxxx Xxxxxxxx xxxxxx jsou x&xxxx;xxxxxxxxx xx xxxx internetové xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxx-xx/xxx-xx-xxx/xxxxxxxxx-xxx-xxxx-xxxxxxxxxx/xxxxxxxx-xx-xxx-xxx-xxxxxxx-xxxxx-xxxxxxxx-xxxx-x-xxxxxxxxx-xxxxxxxx-xxxxxxxx

PŘÍLOHA

Příloha XX xxxxxxxx (XX) č. 1272/2008 xx xxxx takto:

1)

v části 3 xx xxxxxxx 3 xxxx takto:

a)

vkládají xx xxxx xxxxxxx:

Xxxxxxxx číslo

Chemický xxxxx

Xxxxx XX

Xxxxx CAS

Klasifikace

Označení

Specifické xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE

Poznámky

Kódy xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx xxxxxxx a signálních xxxx

Xxxx xxxxxxxxxxxx xxx o nebezpečnosti

Kódy xxxxx. standardních vět x&xxxx;xxxxxxxxxxxxx

„014-052-00-7

xxxxxxxxx, 1,1,1-xxxxxxxxx-X-(xxxxxxxxxxxxxx)-, produkty xxxxxxxxx x&xxxx;xxxxxx xxxxxxxxxx; xxxxxxxxx syntetický amorfní xxxx křemičitý x&xxxx;xxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxx

272-697-1

68909-20-6

XXXX XX 2

X373 (xxxxx) (vdechování)

GHS08

Wng

H373 (xxxxx) (xxxxxxxxxx)

XXX066“

„035-005-00-7

xxxxxx xxxxxx

235-183-8

12124-97-9

Xxxx. 1X

Xxxx.

XXXX XX 3

XXXX XX 1

Xxx Xxxxx. 2

X360XX

X362

X336

X372 (nervový xxxxxx)

X319

XXX08

XXX07

Xxx

X360XX

X362

X336

X372 (xxxxxxx xxxxxx)

X319“

„050-032-00-4

xxxxxxxxxx-xxx(2-xxxxxxxxxxxxx)

220-481-2

2781-10-4

Xxxx. 2

Xxxx. 1X

XXXX RE 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (xxxxxxxx xxxxxx)“

„050-033-00-X

xxxxxxxxxx-xxxxxxxx

213-928-8

1067-33-0

Xxxx. 2

Repr. 1X

XXXX XX 1

X341

X360XX

X372 (xxxxxxxx xxxxxx)

XXX08

Xxx

X341

X360XX

X372 (imunitní xxxxxx)“

„052-001-00-0

xxxxxx

236-813-4

13494-80-9

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„052-002-00-6

xxxx xxxxxxxxxxx

231-193-1

7446-07-3

Xxxx. 1X

Xxxx.

X360Xx

X362

XXX08

Xxx

X360Xx

X362“

„056-005-00-3

xxxxxxxxx xxxxxxx-xxxxxxxx

237-222-4

13701-59-2

Xxxx. 1B

Acute Xxx. 4

Xxxxx Xxx. 3

X360XX

X332

X301

XXX08

XXX06

Xxx

X360XX

X332

X301

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 100&xxxx;xx/xx XX“

„601-097-00-8

xxxxxxxxxxxx

203-132-9

103-65-1

Xxxx. Xxx. 3

Asp. Xxx. 1

XXXX XX 3

Xxxxxxx Xxxxxxx 2

X226

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X304

X335

X411“

„603-243-00-6

xxxxxxxxxxxxxx 2,2-xxxxxxxxxxxxxx-1-xxx; 3-xxxx-2,2-xxx(xxxxxxxxxx)xxxxxx-1-xx

253-057-0

36483-57-5; 1522-92-5

Xxxx. 1X

Xxxx. 2

X350

X341

XXX08

Xxx

X350

X341“

„604-096-00-0

xxxxxxxxxxxxxxxx (XXX); 5-{[2-(2-xxxxxxxxxxxx)xxxxxx]xxxxxx}-6-xxxxxx-1,3-xxxxxxxxxxx

200-076-7

51-03-6

XXXX XX 3

Eye Irrit. 2

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

H335

H319

H400

H410

GHS07

GHS09

Wng

H335

H319

H410

EUH066

M = 1

X&xxxx;= 1“

„604-097-00-6

2,4,6-xxx-xxxx-xxxxxxxxxx

211-989-5

732-26-3

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

Xxxx Xxxx. 1X

X360X

X302

X373 (játra)

H317

GHS08

GHS07

Dgr

H360D

H302

H373 (xxxxx)

X317

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX“

„604-098-00-1

4,4’-xxxxxxxxxxxxxxx; xxxxxxxx X

201-250-5

80-09-1

Xxxx. 1B

H360FD

GHS08

Dgr

H360FD“

„606-153-00-5

benzofenon

204-337-6

119-61-9

Carc. 1X

X350

XXX08

Xxx

X350“

„606-154-00-0

xxxxxxxxxxx (XXX); 2-xxxxx-3-xxxxx-1,4-xxxxxxxxxxx

220-529-2

2797-51-5

Xxxx. 2

Xxxx. 2

Acute Tox. 4

XXXX XX 2

Xxx Xxxxx. 2

Skin Sens. 1&xxxx;X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H351

H361d

H302

H373 (xxxxxx xxxx, ledviny)

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d

H302

H373 (krevní xxxx, xxxxxxx)

X319

X317

X410

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

M = 10“

„607-756-00-6

xxx-1,7,7-xxxxxxxxxxxxxxxx[2.2.1]xxxx-2-xx-xxxxxxx; xxxxxxxxx-xxxxxxx

227-561-6

5888-33-5

Xxxx Sens. 1 A

H317

GHS07

Wng

H317“

„607-757-00-1

daminozid (XXX); 4-(2,2-dimethylhydrazino)-4-oxobutanová xxxxxxxx; X-(xxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx

216-485-9

1596-84-5

Xxxx. 2

H351

GHS08

Wng

H351“

„607-758-00-7

4,4′-oxydi(benzensulfonohydrazid)

201-286-1

80-51-3

Self-react. X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X242

X400

X410

XXX02

XXX09

Xxx

X242

X410

X&xxxx;= 1

X&xxxx;= 1“

„607-759-00-2

xxxxxx-4-xxxxxxxxxxxxxxx

216-407-3

1576-35-8

Xxxx-xxxxx. X

X242

XXX02

Xxx

X242“

„607-760-00-8

2-{X-xxxxx-4-[(5-xxxxxxxxxxxx-2-xx)xxx]-x-xxxxxxxxx}xxxxx-xxxxxx; X.X. Xxxxxxxx Xxxx 124

239-203-6

15141-18-1

Xxxx Xxxx. 1&xxxx;X

X317

XXX07

Xxx

X317

Xxxx Sens. 1&xxxx;X; X317: C ≥ 0,001 %“

„607-761-00-3

perfluorheptanová xxxxxxxx; tridekafluorheptanová kyselina

206-798-9

375-85-9

Repr. 1X

XXXX XX 1

X360X

X372 (xxxxx)

XXX08

Xxx

X360X

X372 (játra)“

„607-762-00-9

methyl-N-(isopropoxykarbonyl)-L-valyl-(3RS)-3-(4-chlorfenyl)-β-alaninát; xxxxxxxxxxx

-

283159-90-0

Xxxx. 2

Xxxxxxx Xxxxxxx 2

X351

X411

XXX08

XXX09

Xxx

X351

X411“

„607-763-00-4

6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina, xxxxx x&xxxx;xxxx(2-xxxxxxxxxxxx)xxxxxx soli

-

-

Repr. 1X

Xxx Xxxxx. 2

X360XX

X319

XXX08

XXX07

Xxx

X360XX

X319“

„607-764-00-X

6-[xxxxx-(X10-X13, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx xxxxxxxx

-

2156592-54-8

Xxxx. 1X

Xxx Xxxxx. 2

X360XX

X319

XXX08

XXX07

Xxx

X360XX

X319“

„607-765-00-5

6-[xxxxx-(X12-X18, xxxxxxxxxx, xxxxxxxxxx)-2,5-xxxxxxxxxxxxxxx-1-xx]xxxxxxxx kyselina

-

-

Repr. 1X

X360XX

XXX08

Xxx

X360XX“

„613-341-00-0

xxxxxxxxxxx (XXX); 3,6-xxx(x-xxxxxxxxxx)-1,2,4,5-xxxxxxxx

277-728-2

74115-24-5

Xxxxxxx Xxxxxxx 1

X410

XXX09

Xxx

X410

X&xxxx;= 1“

„613-342-00-6

theofylin; 1,3-xxxxxxxx-3,7-xxxxxxx-1X-xxxxx-2,6-xxxx

200-385-7

58-55-9

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„613-343-00-1

xxxxxxxxx (XXX); 2,6-xxxxxxx-4-(3,3-xxxxxxxxxxxxxxx)xxxxx{3-[5-(xxxxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxx}xxxxx

-

179101-81-6

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 100“

„613-344-00-7

xxxxxxx-2-xxxxx-1-xxxx, xxxxx xxx; xxxxx xxx xxxxxxxxxx; pyrithion xxxxx

223-296-5;

240-062-8

3811-73-2;

15922-78-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Xxxxx Tox. 4

XXXX RE 1

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 2

X331

X311

X302

X372 (xxxxxxx xxxxxx)

X315

X319

X317

X400

X411

XXX06

XXX08

XXX09

Xxx

X331

X311

X302

X372 (xxxxxxx systém)

H315

H319

H317

H410

EUH070

inhalační:

ATE = 0,5&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxxxx:

XXX&xxxx;= 790&xxxx;xx/xx XX

xxxxxx:

XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 100“

„613-345-00-2

1,3,5-triazin-2,4,6-triamin;

melamin

203-615-4

108-78-1

Carc. 2

XXXX XX 2

X351

X373 (močové xxxxx)

XXX08

Xxx

X351

X373 (xxxxxx cesty)“

„615-046-00-2

1,3-bis(1-isokyanato-1-methylethyl)benzen; [x-XXXXX]

220-474-4

2778-42-9

Xxxx. Xxxx. 1

Xxxx Xxxx. 1 A

H334

H317

GHS08

Dgr

H334

H317“

„615-047-00-8

1,3-bis(isokyanatomethyl)benzen; [x-XXX]

222-852-4

3634-83-1

Xxxx. Xxxx. 1

Xxxx Xxxx. 1&xxxx;X

X334

X317

XXX08

Xxx

X334

X317

Xxxx Xxxx. 1 A; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„615-048-00-3

2,4,6-xxxxxxxxxxxx-x-xxxxxxx-xxxxxxxxxxx

218-485-4

2162-73-4

Xxxx. Xxxx. 1

Xxxx Xxxx. 1

X334

X317

XXX08

Xxx

X334

X317“

„615-049-00-9

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx průměrem xxxxxx xxx 50 μx]

221-641-4

3173-72-6

XXXX XX 3

Xxxx Irrit. 2

Xxx Xxxxx. 2

Xxxx. Xxxx. 1

Skin Xxxx. 1&xxxx;X

Xxxxxxx Xxxxxxx 3

X335

X315

X319

X334

X317

X412

XXX07

XXX08

Xxx

X335

X315

X319

X334

X317

X412“

„615-050-00-4

1,5-xxxxxxxxxxxxxxxxxxxx

[xxxxxxxxxx &xx;&xxxx;0,1&xxxx;% xxxx. xxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx menším xxx 50 μx]

221-641-4

3173-72-6

Xxxxx Xxx. 2

STOT SE 3

Xxxx Irrit. 2

Xxx Xxxxx. 2

Resp. Xxxx. 1

Xxxx Sens. 1 A

Aquatic Xxxxxxx 3

X330

X335

X315

X319

X334

X317

X412

XXX06

XXX08

Xxx

X330

X335

X315

X319

X334

X317

X412

xxxxxxxxx:

XXX&xxxx;= 0,27&xxxx;xx/x (xxxxx xxxx xxxx)“

„616-237-00-3

xxxxxxxxxxx (XXX); 2,6-xxxxxxx-X-[3-xxxxx-5-(xxxxxxxxxxxxxx)-2-xxxxxxx]xxxxxxxxxxxxxx

-

239110-15-7

Xxxx. 2

X361x

XXX08

Xxx

X361x“

„616-238-00-9

xxxxxxx xxxxxxxx X-(2-xxxxxxxxxx)xxxxxxxxxx

477-690-9

874819-71-3

Xxxx. 1B

STOT XX 2

X360Xx

X373 (ledviny)

GHS08

Dgr

H360Fd

H373 (xxxxxxx)“

„616-239-00-4

X-(5-xxxxx-2-xxxxxxxxxxxxxxx)-X-xxxxxxxxxxx-3-(xxxxxxxxxxxxx)-5-xxxxx-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxx

-

1255734-28-1

Xxxx. 2

Xxxxx Xxx. 4

Skin Xxxx. 1X

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X361x

X332

X317

X410

xxxxxxxxx:

XXX&xxxx;= 2,2&xxxx;xx/x (xxxxx nebo mlha)

M = 10

X&xxxx;= 1“

„616-240-00-X

reakční xxxx: 3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx x&xxxx;3-(xxxxxxxxxxxxx)-1-xxxxxx-X-[(1XX,4XX,9XX)-1,2,3,4-xxxxxxxxxx-9-xxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]xxxxxxx-4-xxxxxxxxxx [xxxxxxxxx xxxxx ≥&xxxx;78&xxxx;% xxx-xxxxxxx x&xxxx;≤&xxxx;15&xxxx;% xxxx-xxxxxxx], isopyrazam

-

881685-58-1

Carc. 2

Xxxx. 1X

Xxxx Xxxx. 1X

Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1

H351

H360D

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H317

H410

Repr. 1X; X360X:

X&xxxx;≥&xxxx;3&xxxx;%

X&xxxx;= 10

X&xxxx;= 10“

„650-058-00-1

Xxxxxxx, xxxxxxx [x&xxxx;xxxxx xxxxxxxx Xxxxxxxxxxx indica, xxxxxxxxxxx xxxxx a dále xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx]

283-644-7

84696-25-3

Xxxx. 2

Xxxx Sens. 1

Aquatic Xxxxxxx 1

X361x

X317

X410

XXX08

XXX07

XXX09

Xxx

X361x

X317

X410

X&xxxx;= 10“

b)

položky xxxxxxxxxxxx indexovým xxxxxx 014-001-00-9; 023-001-00-8; 601-024-00-X; 603-014-00-0; 603-107-00-6; 604-030-00-0; 607-111-00-9; 607-230-00-6; 607-253-00-1; 607-254-00-7; 607-734-00-6; 607-735-00-1; 607-736-00-7; 608-032-00-2; 609-042-00-X; 613-012-00-1; 616-164-00-7 xx xxxxxxxxx těmito xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx název

Číslo XX

Xxxxx XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx faktory x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx symbolů x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxx. standardních xxx x&xxxx;xxxxxxxxxxxxx

„014-001-00-9

xxxxxxxxxxxxx

233-042-5

10025-78-2

Xxxx. Xxx. 1

Xxxxx-xxxxx. 1

Acute Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxx. 1&xxxx;X

Xxx Dam. 1

X224

X260

X331

X302

X314

X318

XXX02

XXX06

XXX05

Xxx

X224

X260

X331

X302

X314

XXX014

XXX029

XXX071

xxxxxxxxx:

XXX&xxxx;= 7,6 mg/l (páry)

orální:

ATE = 1&xxxx;000 &xxxx;xx/xx TH“

„023-001-00-8

oxid xxxxxxxxx

215-239-8

1314-62-1

Xxxx. 2

Xxxx. 1X

Xxxx. 2

Xxxx.

Xxxxx Tox. 3

Xxxxx Xxx. 2

XXXX XX 3

XXXX RE 1

Xxxxxxx Xxxxxxx 2

X341

X350

X361xx

X362

X301

X330

X335

X372 (dýchací xxxxx, xxxxxxxxxx)

X411

XXX06

XXX08

XXX09

Xxx

X341

X350

X361xx

X362

X301

X330

X335

X372 (xxxxxxx xxxxx, xxxxxxxxxx)

X411

xxxxxxxxx:

XXX&xxxx;= 0,05 mg/l (xxxxx nebo xxxx)

xxxxxx:

XXX&xxxx;= 220&xxxx;xx/xx XX“

„601-024-00-X

xxxxx

202-704-5

98-82-8

Xxxx. Xxx. 3

Xxxx. 1X

Xxx. Xxx. 1

XXXX SE 3

Xxxxxxx Xxxxxxx 2

X226

X350

X304

X335

X411

XXX02

XXX08

XXX07

XXX09

Xxx

X226

X350

X304

X335

X411“

„603-014-00-0

2-xxxxxxxxxxx-1-xx; ethylenglykol-monobutyl-ether

203-905-0

111-76-2

Acute Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxxx. 2

Xxx Xxxxx. 2

X331

X302

X315

X319

XXX06

Xxx

X331

X302

X315

X319

xxxxxxxxx:

XXX&xxxx;= 3&xxxx;xx/x (xxxx)

xxxxxx:

XXX&xxxx;= 1&xxxx;200 &xxxx;xx/xx XX“

„603-107-00-6

2-(2-xxxxxxxxxxxxx)xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

203-906-6

111-77-3

Xxxx. 1B

H360D

GHS08

Dgr

H360D

Repr. 1X; H360D: C ≥ 3 %“

„604-030-00-0

4,4′-isopropylidendifenol; xxxxxxxx X

201-245-8

80-05-7

Xxxx. 1B

STOT XX 3

Xxx Xxx. 1

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X360X

X335

X318

X317

X400

X410

XXX08

XXX07

XXX05

XXX09

Xxx

X360X

X335

X318

X317

X410

X&xxxx;= 1

X&xxxx;= 10“

„607-111-00-9

2-xxxxx-2-{[(1-xxxxxxxx)xxx]xxxxxx}xxxxxx-1,3-xxxx-xxxxxxxxx; 2,2-xxx(xxxxxxxxxxxxxxxxx)xxxxx-xxxxxxx;

xxxxxxxxxxxxxxxxx-xxxxxxxxxx

239-701-3

15625-89-5

Xxxx. 2

Skin Xxxxx. 2

Xxx Irrit. 2

Skin Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X351

X315

X319

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X315

X319

X317

X410

X&xxxx;= 1

X&xxxx;= 1

X“

„607-230-00-6

2-xxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxx soli, x&xxxx;xxxxxxxx xxxx, xxxxx xxxx xxxxxxx xxxxx x&xxxx;xxxx xxxxxxx

-

-

Xxxx. 1B

H360D

GHS08

Dgr

H360D“

„607-253-00-1

cyfluthrin (ISO); [(3-xxxxxx-4-xxxxxxxxxx)xxxxxxxxxx]-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx

269-855-7

68359-37-5

Xxxx.

Xxxxx Xxx. 2

Xxxxx Xxx. 2

XXXX SE 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X400

X410

XXX06

XXX08

XXX09

Xxx

X362

X330

X300

X370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,14&xxxx;xx/x (prach nebo xxxx)

xxxxxx:

XXX&xxxx;= 14&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-254-00-7

β-xxxxxxxxxx (XXX); reakční směs: xxx-(X)-xxxx(4-xxxxx-3-xxxxxxxxxxx)xxxxxx-(1X,3X)-3-(2,2-xxxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx a rel-(R)-kyan(4-fluor-3-fenoxyfenyl)methyl-(1S,3R)-3-(2,2-dichlorethenyl)-2,2-dimethylcyklopropan-1-karboxylát

-

1820573-27-0

Lact.

Acute Tox. 2

Xxxxx Tox. 2

XXXX XX 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X362

X330

X300

X370 (xxxxxxx systém)

H400

H410

GHS06

GHS08

GHS09

Dgr

H362

H330

H300

H370 (xxxxxxx xxxxxx)

X410

xxxxxxxxx:

XXX&xxxx;= 0,081 mg/l (xxxxx xxxx xxxx)

xxxxxx:

XXX&xxxx;= 11&xxxx;xx/xx XX

X&xxxx;= 1&xxxx;000&xxxx;000

X&xxxx;= 1&xxxx;000&xxxx;000 “

„607-734-00-6

xxxxxxxxxxx-2,2‘,2“,2“‘,2“&xxxx;“ -(xxxxx-1,2-xxxxxxxxxxx)xxxxxxxxxxx

404-290-3

7216-95-7

Xxxx. 1X

Xxxxx Xxx. 4

XXXX RE 2

Xxx Irrit. 2

H360D

H332

H373 (xxxxxxxxxx)

X319

XXX08

XXX07

Xxx

X360X

X332

X373 (xxxxxxxxxx)

X319

Xxxx. 1X; X360X: C ≥ 3 %

inhalační:

ATE = 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-735-00-1

{[(xxxxxxxxxxxxx)xxxxx]xxx(xxxxxxxxxxxxxx)}xxxxxxxxxxx xxxxxxxx

200-652-8

67-43-6

Xxxx. 1X

Xxxxx Tox. 4

XXXX XX 2

Eye Xxxxx. 2

H360D

H332

H373 (vdechování)

H319

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

X319

Xxxx. 1X; X360X: X&xxxx;≥&xxxx;3&xxxx;%

xxxxxxxxx:

XXX&xxxx;= 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„607-736-00-7

xxxxxxxxxxxx-[(xxxxxxxxxxxxxxxxx)xxxxxxxx(xxxxxxxxxxxxxx)xxxxxxxxxxx]

205-391-3

140-01-2

Xxxx. 1B

Acute Xxx. 4

XXXX XX 2

X360X

X332

X373 (vdechování)

GHS08

GHS07

Dgr

H360D

H332

H373 (xxxxxxxxxx)

Xxxx. 1X; X360X: C ≥ 3 %

inhalační:

ATE = 1,5&xxxx;xx/x (xxxxx xxxx xxxx)“

„608-032-00-2

xxxxxxxxxxx (XXX); (1E)-N-[(6-chlorpyridin-3-yl)methyl]-N’-kyan-N-methylethanimidamid; (X)-X 1-[(6-xxxxx-3-xxxxxxx)xxxxxx]-X 2-kyan-N 1-xxxxxxxxxxxxxxxx

-

135410-20-7&xxxx;160430-64-8

Xxxx. 2

Xxxxx Tox. 3

Xxxxxxx Chronic 1

Xxxxxxx Xxxxx 1

H361d

H301

H410

H400

GHS08

GHS06

GHS09

Dgr

H361d

H301

H410

orální:

ATE = 140&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„609-042-00-X

xxxxxxxxxxxxx (XXX); X-(1-xxxxxxxxxxx)-2,6-xxxxxxx-3,4-xxxxxxx

254-938-2

40487-42-1

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 100

M = 10“

„613-012-00-1

xxxxxxxx (XXX); 3-isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-on-2,2-dioxid

246-585-8

25057-89-0

Repr. 2

Xxxxx Xxx. 4

Eye Irrit. 2

Xxxx Sens. 1

X361x

X302

X319

X317

XXX08

XXX07

Xxx

X361x

X302

X319

X317

xxxxxx: XXX&xxxx;= 1&xxxx;600 &xxxx;xx/xx XX“

„616-164-00-7

xxxxxxxxxxxxx (XXX); (2E)-2-{2-[(2,5-dimethylfenoxy)methyl]fenyl}-2-(methoxyimino)-N-methylacetamid; (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

Xxxx. 2

Xxxx. 2

Xxxxx Xxx. 4

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X351

X361x

X332

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X361x

X332

X410

xxxxxxxxx:

XXX&xxxx;= 1,3&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 100

M = 100“

x)

xxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx 615-007-00-X xx xxxxxxx.